Friday, July 31, 2026

Eli Lilly’s Oral GLP-1 Shows 7.9% Weight Loss in Type 2 Diabetes Trial

Eli Lilly's orforglipron shows promise in Phase 3 trials for diabetes and obesity, offering an oral alternative to injectables.

2026 Investment Strategies: How Standard Chartered Korea Recommends Expanding U.S. and Asia Stock Holdings

Standard Chartered Korea recommends diversifying investments in U.S. and Asian stocks, EM bonds, and gold for the second half of 2026.

Samsung SDI Secures 1.5 Billion KRW ESS Battery Supply Deal: What This Means

Samsung SDI secures a $1 billion contract for ESS batteries in the U.S., enhancing its market position amid rising demand for renewables.

Tag: artificial insemination

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.